You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ZARONTIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ZARONTIN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	Children's Hospital Medical Center, Cincinnati	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University Health Center	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ZARONTIN

Condition Name

Chart
Table

Condition Name for ZARONTIN
Intervention	Trials
Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4	1
Neuropathic Traumatic Pain	1
Pain NRS ≥ 4	1
Peripheral Neuropathic Pain	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ZARONTIN
Intervention	Trials
Depressive Disorder	1
Reflex Sympathetic Dystrophy	1
Depression	1
Complex Regional Pain Syndromes	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ZARONTIN

Trials by Country

Map
Table

Trials by Country for ZARONTIN
Location	Trials
United States	23
China	1
France	1
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ZARONTIN
Location	Trials
Pennsylvania	2
Arizona	1
Alabama	1
Wisconsin	1
Washington	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ZARONTIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ZARONTIN
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	2
Phase 1/Phase 2	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ZARONTIN
Clinical Trial Phase	Trials
Completed	2
Terminated	2
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ZARONTIN

Sponsor Name

Chart
Table

Sponsor Name for ZARONTIN
Sponsor	Trials
McGill University Health Center	1
McGill University Health Centre/Research Institute of the McGill University Health Centre	1
Thomas Jefferson University	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ZARONTIN
Sponsor	Trials
Other	9
U.S. Fed	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.